Global Parkinson’s Disease Drugs Market Growth 2018-2023

November 2018 | 137 pages | ID: G745E12C67AEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Parkinson's disease is a type of progressive movement disorder, characterized by muscle rigidity, and tremors.

According to this study, over the next five years the Parkinson’s Disease Drugs market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2023, from US$ xx million in 2017. In particular, this report presents the global market share (sales and revenue) of key companies in Parkinson’s Disease Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Parkinson’s Disease Drugs market by product type, application, key manufacturers and key regions and countries.

This study considers the Parkinson’s Disease Drugs value and volume generated from the sales of the following segments:

Segmentation by product type: breakdown data from 2013 to 2018, in Section 2.3; and forecast to 2023 in section 11.7.

• Oral
• Transdermal
• Subcutaneous
• Intestinal Infusion

Segmentation by application: breakdown data from 2013 to 2018, in Section 2.4; and forecast to 2023 in section 11.8.

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

• Novartis
• F. Hoffmann-La Roche
• AbbVie
• Teva Pharmaceutical Industries
• UCB Inc.
• STADA Arzneimittel
• GlaxoSmithKline
• Valeant Pharmaceuticals International
• Merck
• Impax Laboratories

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

• To study and analyze the global Parkinson’s Disease Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Parkinson’s Disease Drugs market by identifying its various subsegments.
• Focuses on the key global Parkinson’s Disease Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Parkinson’s Disease Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Parkinson’s Disease Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Parkinson’s Disease Drugs Consumption 2013-2023
  2.1.2 Parkinson’s Disease Drugs Consumption CAGR by Region
2.2 Parkinson’s Disease Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Transdermal
  2.2.3 Subcutaneous
  2.2.4 Intestinal Infusion
2.3 Parkinson’s Disease Drugs Consumption by Type
  2.3.1 Global Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Parkinson’s Disease Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Parkinson’s Disease Drugs Sale Price by Type (2013-2018)
2.4 Parkinson’s Disease Drugs Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacy
  2.4.3 Online Pharmacy
2.5 Parkinson’s Disease Drugs Consumption by Application
  2.5.1 Global Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Parkinson’s Disease Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Parkinson’s Disease Drugs Sale Price by Application (2013-2018)

3 GLOBAL PARKINSON’S DISEASE DRUGS BY PLAYERS

3.1 Global Parkinson’s Disease Drugs Sales Market Share by Players
  3.1.1 Global Parkinson’s Disease Drugs Sales by Players (2016-2018)
  3.1.2 Global Parkinson’s Disease Drugs Sales Market Share by Players (2016-2018)
3.2 Global Parkinson’s Disease Drugs Revenue Market Share by Players
  3.2.1 Global Parkinson’s Disease Drugs Revenue by Players (2016-2018)
  3.2.2 Global Parkinson’s Disease Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Parkinson’s Disease Drugs Sale Price by Players
3.4 Global Parkinson’s Disease Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Parkinson’s Disease Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Parkinson’s Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 PARKINSON’S DISEASE DRUGS BY REGIONS

4.1 Parkinson’s Disease Drugs by Regions
  4.1.1 Global Parkinson’s Disease Drugs Consumption by Regions
  4.1.2 Global Parkinson’s Disease Drugs Value by Regions
4.2 Americas Parkinson’s Disease Drugs Consumption Growth
4.3 APAC Parkinson’s Disease Drugs Consumption Growth
4.4 Europe Parkinson’s Disease Drugs Consumption Growth
4.5 Middle East & Africa Parkinson’s Disease Drugs Consumption Growth

5 AMERICAS

5.1 Americas Parkinson’s Disease Drugs Consumption by Countries
  5.1.1 Americas Parkinson’s Disease Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Parkinson’s Disease Drugs Value by Countries (2013-2018)
5.2 Americas Parkinson’s Disease Drugs Consumption by Type
5.3 Americas Parkinson’s Disease Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Parkinson’s Disease Drugs Consumption by Countries
  6.1.1 APAC Parkinson’s Disease Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Parkinson’s Disease Drugs Value by Countries (2013-2018)
6.2 APAC Parkinson’s Disease Drugs Consumption by Type
6.3 APAC Parkinson’s Disease Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Parkinson’s Disease Drugs by Countries
  7.1.1 Europe Parkinson’s Disease Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Parkinson’s Disease Drugs Value by Countries (2013-2018)
7.2 Europe Parkinson’s Disease Drugs Consumption by Type
7.3 Europe Parkinson’s Disease Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Parkinson’s Disease Drugs by Countries
  8.1.1 Middle East & Africa Parkinson’s Disease Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Parkinson’s Disease Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Parkinson’s Disease Drugs Consumption by Type
8.3 Middle East & Africa Parkinson’s Disease Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Parkinson’s Disease Drugs Distributors
10.3 Parkinson’s Disease Drugs Customer

11 GLOBAL PARKINSON’S DISEASE DRUGS MARKET FORECAST

11.1 Global Parkinson’s Disease Drugs Consumption Forecast (2018-2023)
11.2 Global Parkinson’s Disease Drugs Forecast by Regions
  11.2.1 Global Parkinson’s Disease Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Parkinson’s Disease Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Parkinson’s Disease Drugs Forecast by Type
11.8 Global Parkinson’s Disease Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Novartis
  12.1.1 Company Details
  12.1.2 Parkinson’s Disease Drugs Product Offered
  12.1.3 Novartis Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Novartis News
12.2 F. Hoffmann-La Roche
  12.2.1 Company Details
  12.2.2 Parkinson’s Disease Drugs Product Offered
  12.2.3 F. Hoffmann-La Roche Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 F. Hoffmann-La Roche News
12.3 AbbVie
  12.3.1 Company Details
  12.3.2 Parkinson’s Disease Drugs Product Offered
  12.3.3 AbbVie Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 AbbVie News
12.4 Teva Pharmaceutical Industries
  12.4.1 Company Details
  12.4.2 Parkinson’s Disease Drugs Product Offered
  12.4.3 Teva Pharmaceutical Industries Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Teva Pharmaceutical Industries News
12.5 UCB Inc.
  12.5.1 Company Details
  12.5.2 Parkinson’s Disease Drugs Product Offered
  12.5.3 UCB Inc. Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.5.4 Main Business Overview
  12.5.5 UCB Inc. News
12.6 STADA Arzneimittel
  12.6.1 Company Details
  12.6.2 Parkinson’s Disease Drugs Product Offered
  12.6.3 STADA Arzneimittel Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.6.4 Main Business Overview
  12.6.5 STADA Arzneimittel News
12.7 GlaxoSmithKline
  12.7.1 Company Details
  12.7.2 Parkinson’s Disease Drugs Product Offered
  12.7.3 GlaxoSmithKline Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.7.4 Main Business Overview
  12.7.5 GlaxoSmithKline News
12.8 Valeant Pharmaceuticals International
  12.8.1 Company Details
  12.8.2 Parkinson’s Disease Drugs Product Offered
  12.8.3 Valeant Pharmaceuticals International Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.8.4 Main Business Overview
  12.8.5 Valeant Pharmaceuticals International News
12.9 Merck
  12.9.1 Company Details
  12.9.2 Parkinson’s Disease Drugs Product Offered
  12.9.3 Merck Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.9.4 Main Business Overview
  12.9.5 Merck News
12.10 Impax Laboratories
  12.10.1 Company Details
  12.10.2 Parkinson’s Disease Drugs Product Offered
  12.10.3 Impax Laboratories Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.10.4 Main Business Overview
  12.10.5 Impax Laboratories News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Parkinson’s Disease Drugs
Table Product Specifications of Parkinson’s Disease Drugs
Figure Parkinson’s Disease Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Parkinson’s Disease Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Parkinson’s Disease Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Parkinson’s Disease Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Oral
Table Major Players of Oral
Figure Product Picture of Transdermal
Table Major Players of Transdermal
Figure Product Picture of Subcutaneous
Table Major Players of Subcutaneous
Figure Product Picture of Intestinal Infusion
Table Major Players of Intestinal Infusion
Table Global Consumption Sales by Type (2013-2018)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Global Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
Table Global Parkinson’s Disease Drugs Revenue by Type (2013-2018) ($ million)
Table Global Parkinson’s Disease Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Parkinson’s Disease Drugs Value Market Share by Type (2013-2018)
Table Global Parkinson’s Disease Drugs Sale Price by Type (2013-2018)
Figure Parkinson’s Disease Drugs Consumed in Hospital Pharmacy
Figure Global Parkinson’s Disease Drugs Market: Hospital Pharmacy (2013-2018) (K Units)
Figure Global Parkinson’s Disease Drugs Market: Hospital Pharmacy (2013-2018) ($ Millions)
Figure Global Hospital Pharmacy YoY Growth ($ Millions)
Figure Parkinson’s Disease Drugs Consumed in Retail Pharmacy
Figure Global Parkinson’s Disease Drugs Market: Retail Pharmacy (2013-2018) (K Units)
Figure Global Parkinson’s Disease Drugs Market: Retail Pharmacy (2013-2018) ($ Millions)
Figure Global Retail Pharmacy YoY Growth ($ Millions)
Figure Parkinson’s Disease Drugs Consumed in Online Pharmacy
Figure Global Parkinson’s Disease Drugs Market: Online Pharmacy (2013-2018) (K Units)
Figure Global Parkinson’s Disease Drugs Market: Online Pharmacy (2013-2018) ($ Millions)
Figure Global Online Pharmacy YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Global Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
Table Global Parkinson’s Disease Drugs Value by Application (2013-2018)
Table Global Parkinson’s Disease Drugs Value Market Share by Application (2013-2018)
Figure Global Parkinson’s Disease Drugs Value Market Share by Application (2013-2018)
Table Global Parkinson’s Disease Drugs Sale Price by Application (2013-2018)
Table Global Parkinson’s Disease Drugs Sales by Players (2016-2018) (K Units)
Table Global Parkinson’s Disease Drugs Sales Market Share by Players (2016-2018)
Figure Global Parkinson’s Disease Drugs Sales Market Share by Players in 2016
Figure Global Parkinson’s Disease Drugs Sales Market Share by Players in 2017
Table Global Parkinson’s Disease Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Parkinson’s Disease Drugs Revenue Market Share by Players (2016-2018)
Figure Global Parkinson’s Disease Drugs Revenue Market Share by Players in 2016
Figure Global Parkinson’s Disease Drugs Revenue Market Share by Players in 2017
Table Global Parkinson’s Disease Drugs Sale Price by Players (2016-2018)
Figure Global Parkinson’s Disease Drugs Sale Price by Players in 2017
Table Global Parkinson’s Disease Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Parkinson’s Disease Drugs Products Offered
Table Parkinson’s Disease Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Parkinson’s Disease Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Parkinson’s Disease Drugs Consumption Market Share by Regions 2013-2018
Figure Global Parkinson’s Disease Drugs Consumption Market Share by Regions 2013-2018
Table Global Parkinson’s Disease Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Parkinson’s Disease Drugs Value Market Share by Regions 2013-2018
Figure Global Parkinson’s Disease Drugs Value Market Share by Regions 2013-2018
Figure Americas Parkinson’s Disease Drugs Consumption 2013-2018 (K Units)
Figure Americas Parkinson’s Disease Drugs Value 2013-2018 ($ Millions)
Figure APAC Parkinson’s Disease Drugs Consumption 2013-2018 (K Units)
Figure APAC Parkinson’s Disease Drugs Value 2013-2018 ($ Millions)
Figure Europe Parkinson’s Disease Drugs Consumption 2013-2018 (K Units)
Figure Europe Parkinson’s Disease Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Parkinson’s Disease Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Parkinson’s Disease Drugs Value 2013-2018 ($ Millions)
Table Americas Parkinson’s Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Parkinson’s Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Parkinson’s Disease Drugs Consumption Market Share by Countries in 2017
Table Americas Parkinson’s Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Parkinson’s Disease Drugs Value Market Share by Countries (2013-2018)
Figure Americas Parkinson’s Disease Drugs Value Market Share by Countries in 2017
Table Americas Parkinson’s Disease Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Parkinson’s Disease Drugs Consumption Market Share by Type in 2017
Table Americas Parkinson’s Disease Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Parkinson’s Disease Drugs Consumption Market Share by Application in 2017
Figure United States Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Parkinson’s Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Parkinson’s Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Parkinson’s Disease Drugs Consumption Market Share by Countries in 2017
Table APAC Parkinson’s Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Parkinson’s Disease Drugs Value Market Share by Countries (2013-2018)
Figure APAC Parkinson’s Disease Drugs Value Market Share by Countries in 2017
Table APAC Parkinson’s Disease Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Parkinson’s Disease Drugs Consumption Market Share by Type in 2017
Table APAC Parkinson’s Disease Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Parkinson’s Disease Drugs Consumption Market Share by Application in 2017
Figure China Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure China Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure India Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure India Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Parkinson’s Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Parkinson’s Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Parkinson’s Disease Drugs Consumption Market Share by Countries in 2017
Table Europe Parkinson’s Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Parkinson’s Disease Drugs Value Market Share by Countries (2013-2018)
Figure Europe Parkinson’s Disease Drugs Value Market Share by Countries in 2017
Table Europe Parkinson’s Disease Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Parkinson’s Disease Drugs Consumption Market Share by Type in 2017
Table Europe Parkinson’s Disease Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Parkinson’s Disease Drugs Consumption Market Share by Application in 2017
Figure Germany Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure France Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure France Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Parkinson’s Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Parkinson’s Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Parkinson’s Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Parkinson’s Disease Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Parkinson’s Disease Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Parkinson’s Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Parkinson’s Disease Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Parkinson’s Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Parkinson’s Disease Drugs Consumption Market Share by Application in 2017
Figure Egypt Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Parkinson’s Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Parkinson’s Disease Drugs Value Growth 2013-2018 ($ Millions)
Table Parkinson’s Disease Drugs Distributors List
Table Parkinson’s Disease Drugs Customer List
Figure Global Parkinson’s Disease Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Parkinson’s Disease Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Parkinson’s Disease Drugs Consumption Market Forecast by Regions
Table Global Parkinson’s Disease Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Drugs Value Market Share Forecast by Regions
Figure Americas Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Americas Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure APAC Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure APAC Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Europe Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Europe Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure United States Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure United States Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Canada Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Canada Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Mexico Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Mexico Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Brazil Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Brazil Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure China Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure China Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Japan Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Japan Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Korea Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Korea Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure India Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure India Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Australia Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Australia Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Germany Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Germany Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure France Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure France Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure UK Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure UK Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Italy Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Italy Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Russia Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Russia Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Spain Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Spain Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Egypt Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Egypt Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure South Africa Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure South Africa Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Israel Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Israel Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure Turkey Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure Turkey Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Parkinson’s Disease Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Parkinson’s Disease Drugs Value 2018-2023 ($ Millions)
Table Global Parkinson’s Disease Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Parkinson’s Disease Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Parkinson’s Disease Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Parkinson’s Disease Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Parkinson’s Disease Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Parkinson’s Disease Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Parkinson’s Disease Drugs Value Market Share Forecast by Application (2018-2023)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Parkinson’s Disease Drugs Market Share (2016-2018)
Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table F. Hoffmann-La Roche Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure F. Hoffmann-La Roche Parkinson’s Disease Drugs Market Share (2016-2018)
Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table AbbVie Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure AbbVie Parkinson’s Disease Drugs Market Share (2016-2018)
Table Teva Pharmaceutical Industries Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Teva Pharmaceutical Industries Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Teva Pharmaceutical Industries Parkinson’s Disease Drugs Market Share (2016-2018)
Table UCB Inc. Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table UCB Inc. Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure UCB Inc. Parkinson’s Disease Drugs Market Share (2016-2018)
Table STADA Arzneimittel Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table STADA Arzneimittel Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure STADA Arzneimittel Parkinson’s Disease Drugs Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Parkinson’s Disease Drugs Market Share (2016-2018)
Table Valeant Pharmaceuticals International Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Valeant Pharmaceuticals International Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Valeant Pharmaceuticals International Parkinson’s Disease Drugs Market Share (2016-2018)
Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Merck Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Merck Parkinson’s Disease Drugs Market Share (2016-2018)
Table Impax Laboratories Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Impax Laboratories Parkinson’s Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Impax Laboratories Parkinson’s Disease Drugs Market Share (2016-2018)